scholarly article | Q13442814 |
P2093 | author name string | M Ito | |
K Watanabe | |||
K Onodera | |||
T Yasuda | |||
T Goto | |||
Y Inamoto | |||
K Miyamura | |||
S Tsukamoto | |||
Y Ozawa | |||
S Nishiwaki | |||
D Koyama | |||
A Seto | |||
N Imahashi | |||
M Imahashi | |||
P2860 | cites work | Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT | Q24685958 |
Macrophage inflammatory protein-1 | Q28211059 | ||
A reversible posterior leukoencephalopathy syndrome | Q28273132 | ||
Macrophage activation syndrome: advances towards understanding pathogenesis | Q28284000 | ||
2. Cytokines and chemokines | Q30310536 | ||
Intestinal thrombotic microangiopathy after allogeneic bone marrow transplantation: a clinical imitator of acute enteric graft-versus-host disease. | Q33360369 | ||
Estimation of failure probabilities in the presence of competing risks: new representations of old estimators | Q33594562 | ||
Pathophysiologic mechanisms of acute graft-vs.-host disease | Q33793177 | ||
The phagocytes: neutrophils and monocytes | Q34013216 | ||
The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HLA-B, and HLA-DR matched unrelated donors | Q34128401 | ||
An overview of the immune system | Q34280088 | ||
Engraftment syndrome following hematopoietic stem cell transplantation | Q34298239 | ||
Targeting to macrophages: role of physicochemical properties of particulate carriers--liposomes and microspheres--on the phagocytosis by macrophages. | Q34537587 | ||
Hemophagocytic syndromes | Q34641523 | ||
Hepatic Veno-occlusive Disease (Sinusoidal Obstruction Syndrome) After Hematopoietic Stem Cell Transplantation | Q35126479 | ||
Counting the cost: markers of endothelial damage in hematopoietic stem cell transplantation | Q35934133 | ||
Long-term follow-up of patients who experienced graft failure postallogeneic progenitor cell transplantation. Results of a single institution analysis | Q35994849 | ||
Human natural killer cells | Q36787596 | ||
Scavenger receptor CD163, a Jack-of-all-trades and potential target for cell-directed therapy | Q37714121 | ||
Incidence, predisposing factors, and outcome of engraftment syndrome in pediatric allogeneic stem cell transplant recipients | Q40424504 | ||
Engraftment syndrome after nonmyeloablative allogeneic hematopoietic stem cell transplantation: incidence and effects on survival | Q40505136 | ||
Hemophagocytic syndrome: a rare complication of allogeneic nonmyeloablative hematopoietic stem cell transplantation | Q40581425 | ||
Inhibitors of haemopoiesis and their potential clinical relevance. | Q41137657 | ||
Liposomal methylprednisolone differentially regulates the expression of TNF and IL-10 in human alveolar macrophages | Q45225864 | ||
Encouraging results of low-dose etoposide in the treatment of early-onset hemophagocytic syndrome following allogeneic hematopoietic stem cell transplantation | Q46810363 | ||
Tumor necrosis factor-alpha blockade for the treatment of acute GVHD. | Q47804385 | ||
Impact of macrophage infiltration of skin lesions on survival after allogeneic stem cell transplantation: a clue to refractory graft-versus-host disease. | Q50601549 | ||
Clinicopathological manifestations and treatment of intestinal transplant-associated microangiopathy. | Q50622232 | ||
Macrophage activation syndrome as the presenting manifestation of rheumatic diseases in childhood. | Q53620332 | ||
CD163 | Q56593680 | ||
Proinflammatory cytokines and their role in the development of major transplant-related complications in the early phase after allogeneic bone marrow transplantation | Q73432062 | ||
Macrophages and their subpopulations following allogenic bone marrow transplantation for chronic myeloid leukaemia | Q74330699 | ||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 387-394 | |
P577 | publication date | 2011-04-18 | |
P1433 | published in | Bone Marrow Transplantation | Q4941523 |
P1476 | title | Clinical significance of hemophagocytosis in BM clot sections during the peri-engraftment period following allogeneic hematopoietic SCT. | |
P478 | volume | 47 |
Q51028682 | Association of Plasma CD163 Concentration with De Novo-Onset Chronic Graft-versus-Host Disease. |
Q50225125 | Dexamethasone palmitate for patients with engraftment syndrome is associated with favorable outcome for children with hematological malignancy |
Q44295675 | Dexamethasone palmitate successfully attenuates hemophagocytic syndrome after allogeneic stem cell transplantation: macrophage-targeted steroid therapy |
Q40889851 | Hemophagocytic syndrome following haploidentical peripheral blood stem cell transplantation with post-transplant cyclophosphamide. |
Q48337197 | Increase of bone marrow macrophages and CD8+ T lymphocytes predict graft failure after allogeneic bone marrow or cord blood transplantation |
Q27011625 | Making sense of the cytokine storm: a conceptual framework for understanding, diagnosing, and treating hemophagocytic syndromes |
Q90703653 | My jamais vu in post allogeneic hematopoietic cell transplant: a review on secondary hemophagocytosis in adults |
Q91813399 | Role of interferon-γ in immune-mediated graft failure after allogeneic hematopoietic stem cell transplantation |
Search more.